围术期苯二氮䓬类药物对术中知晓及术后谵妄的影响:系统综述与Meta分析
系统检索多个数据库,纳入34项RCT(n=4354)和9项观察性研究(n=3309),比较围术期苯二氮䓬类与其他药物或安慰剂的术中知晓、术后谵妄和死亡率。结果显示苯二氮䓬类不增加谵妄风险,但降低术中知晓风险;与右美托咪定相比谵妄风险增加。
要点
- 围术期苯二氮䓬类未增加术后谵妄风险(RR 1.43,95%CI 0.9-2.27,P=0.13)。
- 与右美托咪定相比,苯二氮䓬类增加谵妄风险(RR 1.83,95%CI 1.24-2.72,P=0.002)。
- 围术期苯二氮䓬类降低术中知晓风险(RR 0.26,95%CI 0.12-0.58,P=0.001)。
核心结论
- 围术期苯二氮䓬类不增加术后谵妄,但降低术中知晓风险。
- 既往苯二氮䓬类与谵妄的关联可能由与右美托咪定的比较所致。
研究设计与样本
- 系统综述与Meta分析,检索CENTRAL、MEDLINE、CINAHL、PsycInfo和Web of Science至2021年6月。
- 纳入34项随机对照试验(n=4354)和9项前瞻性观察性研究(n=3309),观察性研究单独分析。
主要发现
- 围术期苯二氮䓬类未增加谵妄风险(n=1352;RR 1.43;95%CI 0.9-2.27;I2=72%;P=0.13;极低质量证据)。
- 与右美托咪定相比,苯二氮䓬类增加谵妄风险(5项研究;n=429;RR 1.83;95%CI 1.24-2.72;I2=13%;P=0.002)。
- 围术期苯二氮䓬类降低术中知晓风险(n=2245;RR 0.26;95%CI 0.12-0.58;I2=35%;P=0.001;极低质量证据)。
- 考虑非事件时,围术期苯二氮䓬类增加无术中知晓概率(RR 1.07;95%CI 1.01-1.13;I2=98%;P=0.03;极低质量证据)。
- 死亡率仅1项RCT报告(n=800;RR 0.90;95%CI 0.20-3.1;P=0.80;极低质量证据)。
临床怎么用
- 围术期使用苯二氮䓬类需权衡谵妄与术中知晓风险,尤其与右美托咪定比较时。
- 对谵妄高风险患者,选择右美托咪定可能优于苯二氮䓬类。
局限性
- 证据质量极低(谵妄、术中知晓和死亡率结局)。
- 观察性研究单独分析,异质性较高(I2最高达98%)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Benzodiazepine use is associated with delirium, and guidelines recommend avoiding them in older and critically ill patients. Their perioperative use remains common because of perceived benefits. METHODS: We searched CENTRAL, MEDLINE, CINAHL, PsycInfo, and Web of Science from inception to June 2021. Pairs of reviewers identified randomised controlled trials and prospective observational studies comparing perioperative use of benzodiazepines with other agents or placebo in patients undergoing surgery. Two reviewers independently abstracted data, which we combined using a random-effects model. Our primary outcomes were delirium, intraoperative awareness, and mortality. RESULTS: We included 34 randomised controlled trials (n=4354) and nine observational studies (n=3309). Observational studies were considered separately. Perioperative benzodiazepines did not increase the risk of delirium (n=1352; risk ratio [RR] 1.43; 95% confidence interval [CI]: 0.9-2.27; I2=72%; P=0.13; very low-quality evidence). Use of benzodiazepines instead of dexmedetomidine did, however, increase the risk of delirium (five studies; n=429; RR 1.83; 95% CI: 1.24-2.72; I2=13%; P=0.002). Perioperative benzodiazepine use decreased the risk of intraoperative awareness (n=2245; RR 0.26; 95% CI: 0.12-0.58; I2=35%; P=0.001; very low-quality evidence). When considering non-events, perioperative benzodiazepine use increased the probability of not having intraoperative awareness (RR 1.07; 95% CI: 1.01-1.13; I2=98%; P=0.03; very low-quality evidence). Mortality was reported by one randomised controlled trial (n=800; RR 0.90; 95% CI: 0.20-3.1; P=0.80; very low quality). CONCLUSIONS: In this systematic review and meta-analysis, perioperative benzodiazepine use did not increase postoperative delirium and decreased intraoperative awareness. Previously observed relationships of benzodiazepine use with delirium could be explained by comparisons with dexmedetomidine. SYSTEMATIC REVIEW PROTOCOL: PROSPERO CRD42019128144.
引用
- Wang E, Belley-Côté EP, Young J, et al. Effect of perioperative benzodiazepine use on intraoperative awareness and postoperative delirium: a systematic review and meta-analysis of randomised controlled trials and observational studies. Br J Anaesth. 2023. PMID: 36621439. doi:10.1016/j.bja.2022.12.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。